The R&D analysis firm said the online platform, the Site Contracts Application, holds information regarding more than 100,000 Phase II and III clinical contracts from approximately 100 countries.
The firm said the application will help firms reduce contract cycle times - the duration between protocol approval and clinical trial report - and inform plans based on study phase, whether the site is independent or public, budget cycle time, therapy area, and location.
“With increasingly complex and long cycle times for investigative site clinical trial contracts, the Site Contracts Application provides previously unavailable industry contract benchmarks,” said KMR.
Anyone involved with incorporating site contract cycle times into overall trial plans will benefit from this application, added president Linda Martin.
According to the firm, more than 20 firms are represented in the application, with data dating back to 2010.
In 2016, KMR Group launched an online clinical trial performance application to help inform firms on trial performance, recruitment, and site metrics data.